# Heparin Sodium Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 8
- Latest FDA row update: 08/17/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- B. Braun Medical Inc. — Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) — FDA availability: Available — updated: 08/07/2026
- B. Braun Medical Inc. — Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) — FDA availability: Available — updated: 08/07/2026
- Baxter Healthcare — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) — FDA availability: Available — updated: 08/17/2026
- Fresenius Kabi USA, LLC — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) — FDA availability: Available — updated: 08/04/2026
- Fresenius Kabi USA, LLC — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) — FDA availability: Available — updated: 08/04/2026
- Hospira, Inc., a Pfizer Company — Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59) — FDA availability: Available — updated: 08/07/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/heparin-sodium-injection)
- [JSON record](https://citefacts.com/shortages/heparin-sodium-injection.json)